Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5 mg a) 30 count (NDC 68180-413-06) and b) 90 count (NDC 68180-413-09) bottles, Rx only

D-0089-2022

October 12, 2021

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 88856
Status
Terminated
Classification
Class II
Quantity
63,408 bottles
Official record key
drug-enforcement:D-0089-2022

Official wording

Reason: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Code information: a) Lot# H804537, exp. date 30/09/2021 H805148, exp. date 31/10/2021 H900063, exp. date 31/10/2021 H900522, exp. date 31/12/2021 H901582, exp. date 31/01/2022 b) Lot# H000963, exp. date 30/04/2022 H804507, exp. date 30/04/2022 H804536, exp. date 30/09/2021 H805070, exp. date 31/10/2021 H805149, exp. date 31/10/2021 H900064, exp. date 31/12/2021 H900523, exp. date 31/01/2022 H901583, exp. date 30/04/2022 H902530, exp. date 30/04/2022

Distribution pattern: Product was distributed to major distributors who may have further distributed the product nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity N-nitrosoirbesartan detected in API
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations